What is Merge Bio Therapeutics worth?
$23.0Mlast known valuation
Merge Bio Therapeutics last raised $5.0M in its Seed Round (Aug 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Merge Bio Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Seed Round | $5.0M | ▮ | ▮ |
How Merge Bio Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Merge Bio Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Merge Bio Therapeutics worth?
- Merge Bio Therapeutics's last known valuation is $23.0M.
- How much has Merge Bio Therapeutics raised?
- Merge Bio Therapeutics has raised $5.0M in total funding across 1 recorded rounds.
- When did Merge Bio Therapeutics last raise?
- Merge Bio Therapeutics last raised in Aug 2025 (Seed Round), raising $5.0M.